Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
03/2012
03/08/2012WO2012029836A1 Method for producing 1-triazole-2-butanol derivative
03/08/2012WO2012029825A1 Influenza preventative and/or therapeutic agent
03/08/2012WO2012029792A1 Compound having activity for inhibiting tgf-β receptor activation, method for screening same, and composition for prevention or treatment of hepatitis c virus-induced diseases
03/08/2012WO2012029529A1 Eggshell membrane solubilization method using enzymes
03/08/2012WO2012028758A1 Use of crassula for treating proliferative diseases
03/08/2012WO2012028732A1 Novel uses of v-atpase inhibitors
03/08/2012WO2012028479A1 Material combination for treating inflammatory or infectious diseases
03/08/2012WO2012028106A1 Deuterium-enriched heterocyclic compounds as kinase inhibitors
03/08/2012WO2012028089A1 Use of interleukin-22 in treating viral hepatitis
03/08/2012WO2012027972A1 TENOFOVIR DISOPROXIL FUMARATE α-CRYSTAL FORM, PREPARATION METHOD AND APPLICATION THEREOF
03/08/2012WO2012027850A1 Peptide containing multiple n-linked glycosylation sequons
03/08/2012WO2011158248A3 Process for preparation of posaconazole and crystalline polymorphic form v of posaconazole
03/08/2012WO2011151618A3 Compounds for the treatment of clostridium difficile associated disease (cdad)
03/08/2012WO2011146612A3 Latent human immunodeficiency virus reactivation
03/08/2012WO2011140550A3 Immunogen adherence and method of making and using same
03/08/2012WO2011139881A3 Compositions containing purine and pyrimidine nucleosides, peptides, and manganese and their uses
03/08/2012WO2011133727A3 Anti-viral compounds
03/08/2012WO2011116138A3 Peptide antimicrobials
03/08/2012WO2001000832A9 Methods for making apo-2 ligand using divalent metal ions
03/08/2012US20120060230 Methods and compositions for modification of a hla locus
03/08/2012US20120059151 Non-Functional P2X7 Receptor
03/08/2012US20120059057 Antiviral treatments
03/08/2012US20120059046 Inhibition of map4k4 through rnai
03/08/2012US20120059044 Methods of utilizing the arrestin-2/stam-1 complex as a therapeutic target
03/08/2012US20120059038 Polyketide compound
03/08/2012US20120059028 Thieno [2, 3-b] pyridine derivatives as viral replication inhibitors
03/08/2012US20120059026 Antimicrobial agents
03/08/2012US20120059023 Use of polymorphic forms of rifaximin for medical preparations
03/08/2012US20120059019 Compounds for the Treatment of Hepatitis C
03/08/2012US20120058995 Methods of chemical synthesis of diaminophenothiazinium compounds involving the use of persulfate oxidants
03/08/2012US20120058989 Antibacterial fluoroquinolone analogs
03/08/2012US20120058986 Di-azetidinyl diamide as monoacylglycerol lipase inhibitors
03/08/2012US20120058984 Pyrimidine derivatives used as itk inhibitors
03/08/2012US20120058981 Androgen pharmaceutical composition and method for treating depression
03/08/2012US20120058977 Pharmaceutical compositions and methods for treating tuberculosis
03/08/2012US20120058975 Phosphonate Compounds
03/08/2012US20120058964 Pharmaceutical formulation
03/08/2012US20120058960 Feedback prodrug
03/08/2012US20120058959 Topical antiviral formulations
03/08/2012US20120058937 Prodrugs of Neuraminidase Inhibitors
03/08/2012US20120058936 Compositions and methods for elimination of gram negative bacteria
03/08/2012US20120058935 Antimicrobial compositions and methods of use therefore
03/08/2012US20120058487 Compositions and methods for detecting klebsiella pneumoniae
03/08/2012US20120058211 Defined dose therapeutic phage
03/08/2012US20120058199 Compositions, use and method for the use of surface active proteins in topical drug delivery across keratin
03/08/2012US20120058198 Methods for treating and preventing pneumonia and ventilator-associated tracheobronchitis
03/08/2012US20120058188 Lipid encapsulated interfering rna
03/08/2012US20120058180 Liver-specific Nanocapsules and Methods of Using
03/08/2012US20120058162 Stable, spray dryed, immunogenic, viral compositions
03/08/2012US20120058156 Activated leukocyte composition and uses for wound healing
03/08/2012US20120058154 Synthetic nanocarrier vaccines comprising peptides obtained or derived from human influenza a virus m2e
03/08/2012US20120058153 Synthetic nanocarrier vaccines comprising proteins obtained or derived from human influenza a virus hemagglutinin
03/08/2012US20120058150 Methods for Delivering Compositions by Electrospraying a Medical Device
03/08/2012US20120058149 Treatment of infection
03/08/2012US20120058148 Certain aminoalkyl glucosaminide phosphate compounds and their use
03/08/2012US20120058145 Method for producing virus from cell culture involving homogenization
03/08/2012US20120058144 Lipids and compositions for the delivery of therapeutics
03/08/2012US20120058143 Staphylococcus aureus proteins and nucleic acids
03/08/2012US20120058142 Vaccine for protection against shigella sonnei disease
03/08/2012US20120058137 Efficient transport into white blood cells
03/08/2012US20120058136 NON-SPLICING VARIANTS OF gp350/220
03/08/2012US20120058135 Identification and characterization of racemases, definition of protein signatures, and a test for detecting D-amino acid and for screening molecules capable of inhibiting the activity of racemase, especially proline racemase
03/08/2012US20120058133 Inhibition of trna synthetases and therapeutic applications thereof
03/08/2012US20120058128 Anti- integrin antibodies, compositions, methods and uses
03/08/2012US20120058127 PAR2 Agonists for Use in the Treatment or Prevention of Influenza Virus Type A Infections
03/08/2012US20120058124 Influenza virus-neutralizing antibody and screening method therefor
03/08/2012US20120058104 Use of a fermented soy extract as a prebiotic composition
03/08/2012US20120058102 Pharmacologically induced transgene ablation system
03/08/2012US20120058101 Treatment of human or animal body surface infection
03/08/2012US20120058100 Modulation of drug release rate from electrospun fibers
03/08/2012US20120058092 Process for the preparation of a composition of genetically modified hematopoietic progenitor cells
03/08/2012US20120058087 Diagnosis of endometritis
03/08/2012US20120058085 Deuterium Modified Benzimidazoles
03/08/2012US20120058084 Interferon Alpha Carrier Prodrugs
03/08/2012US20120058081 Ex-vivo treatment of peripheral blood leukocytes with IFN-lambda
03/08/2012US20120058080 7-Nitro-2-(3-nitro phenyl)-4H-3,1-benzoxazin-4-one or derivatives thereof for treating or preventing antiviral infections
03/08/2012US20120058079 1,2,5-Oxadiazoles as Inhibitors of Indoleamine 2,3-Dioxygenase
03/08/2012US20120058075 Novel methods for cleaning a surface
03/08/2012US20120058062 Two component interactive emulsion product
03/08/2012CA2812044A1 Methods of treating bacterial infections through pulmonary delivery of fusidic acid
03/08/2012CA2810005A1 Fused tricyclic ether carbamates and their use
03/08/2012CA2809900A1 Use of interleukin-22 in treating viral hepatitis
03/08/2012CA2809890A1 Peptide containing multiple n-linked glycosylation sequons
03/08/2012CA2809837A1 Human immunodeficiency virus (hiv)-neutralizing antibodies
03/08/2012CA2809780A1 Influenza virus neutralizing antibody and method for screening same
03/08/2012CA2809679A1 Phosphonate ester derivatives and methods of synthesis thereof
03/08/2012CA2809535A1 Antifungal composition
03/08/2012CA2808230A1 Process for producing 1-triazole-2-butanol derivatives
03/07/2012EP2426150A1 Anti-NKG2A antibodies and uses thereof
03/07/2012EP2425837A1 Use of cell autophagy (type ii cell apoptosis) inhibitors
03/07/2012EP2424987A2 Antisense oligonucleotides of hemoglobins
03/07/2012EP2424974A1 Mutants of francisella tularensis and uses thereof
03/07/2012EP2424897A1 Anti cxcr4 antibodies for the treatment of hiv
03/07/2012EP2424885A2 Compositions and methods for the treatment of disorders involving epithelial cell apoptosis
03/07/2012EP2424879A1 Influenza vaccine
03/07/2012EP2424864A1 Oxazole substituted indazoles as pi3-kinase inhibitors
03/07/2012EP2424829A2 Omega-cyclohexylalkan-1-oles and use thereof as antimicrobial actives to combat body odor
03/07/2012EP2424559A1 Methods of treating bacterial infections using oritavancin
03/07/2012EP2424550A1 Inactivated bacterial cell formulation
03/07/2012EP2424536A2 Novel photosensitizer formulations for oral administration
1 ... 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 ... 1798